Back

Refining definitions of severe and advanced heart failure: insight from the swedish heart failure registry to optimize trial design and improve referral to advanced therapies

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Advances in heart failure therapeutics Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Federica Guidetti

Inselspital - University of Bern, Bern (Switzerland)

4 More presentations in this session

Presentation thumbnail
Association between neutrophil-to-lymphocyte ratio, exercise capacity and outcomes in patients with heart failure and reduced ejection fraction
Doctor E. Rodenas Alesina (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Sodium zirconium cyclosilicate for the management of hyperkalaemia in patients with heart failure with reduced ejection fraction - the REALIZE-K open-label run-in phase
Professor M. Petrie (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Relative and absolute benefit of dapagliflozin using different eGFR estimates: insights from DAPA-HF trial
Doctor P. Tolomeo (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Cardiac rhythm management devices in patients with heart failure - preliminary results of the DIRECT HF international survey on patients' needs and perceptions
Ms R. Monroe (Charlotte, US)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in heart failure therapeutics

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
The incidence of severe heart failure among hospitalized patients with HFrEF. Do we have a simplified diagnostic criteria helping in the earlier diagnosis and better prognosis?
thumbnail
Congress Presentation
Event rates in major phase 3 heart failure trials over the past 20 years
thumbnail
Congress Presentation
Two-year outcomes in acute heart failure patients stratified by left ventricular ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources